Litcius/Paper detail

Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations

Justin A. Chen, Jonathan W. Riess

2020Current Treatment Options in Oncology21 citationsDOI

Topics & Concepts

MedicineOncologyInternal medicineCancer researchCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsColorectal Cancer Treatments and Studies
Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations | Litcius